These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trisomy 2 as the sole chromosomal abnormality in a hepatoblastoma. Bardi G; Johansson B; Pandis N; Heim S; Mandahl N; Békássy A; Hägerstrand I; Mitelman F Genes Chromosomes Cancer; 1992 Jan; 4(1):78-80. PubMed ID: 1377013 [TBL] [Abstract][Full Text] [Related]
4. Type 1a glycogen storage disease with hepatoblastoma in siblings. Ito E; Sato Y; Kawauchi K; Munakata H; Kamata Y; Yodono H; Yokoyama M Cancer; 1987 May; 59(10):1776-80. PubMed ID: 3030527 [TBL] [Abstract][Full Text] [Related]
10. Fine needle aspiration cytology of undifferentiated small cell ("anaplastic") hepatoblastoma. A case report. Kaw YT; Hansen K Acta Cytol; 1993; 37(2):216-20. PubMed ID: 8385412 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma. Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322 [TBL] [Abstract][Full Text] [Related]
13. Paediatric hepatoblastoma and hepatocellular carcinoma: retrospective study. Chan KL; Fan ST; Tam PK; Chiang AK; Chan GC; Ha SY Hong Kong Med J; 2002 Feb; 8(1):13-7. PubMed ID: 11861987 [TBL] [Abstract][Full Text] [Related]
14. Hepatoblastoma in a 2-year-old girl with trisomy 18. Tanaka K; Uemoto S; Asonuma K; Katayama T; Utsunomiya H; Akiyama Y; Sasaki MS; Ozawa K Eur J Pediatr Surg; 1992 Oct; 2(5):298-300. PubMed ID: 1329941 [TBL] [Abstract][Full Text] [Related]
15. High mobility group AT-hook 2 is overexpressed in hepatoblastoma. Lee CT; Zhang L; Mounajjed T; Wu TT Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771 [TBL] [Abstract][Full Text] [Related]
16. Association between hepatoblastoma and polyposis coli. Kingston JE; Herbert A; Draper GJ; Mann JR Arch Dis Child; 1983 Dec; 58(12):959-62. PubMed ID: 6318669 [TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873 [TBL] [Abstract][Full Text] [Related]
18. Hepatoblastoma. A case report. Akoojee SB; Coovadia YM S Afr Med J; 1978 Sep; 54(11):450-2. PubMed ID: 216126 [TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426 [TBL] [Abstract][Full Text] [Related]
20. Hepatoblastomas in mice in the US National Toxicology Program (NTP) studies. Turusov VS; Torii M; Sills RC; Willson GA; Herbert RA; Hailey JR; Haseman JK; Boorman GA Toxicol Pathol; 2002; 30(5):580-91. PubMed ID: 12371667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]